KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed)

The KUH P30 Resource Core Center grant opportunity is issued by the National Institutes of Health under the U.S. Department of Health and Human Services, specifically aligned with the mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases. This funding initiative is designed to support the development and operation of Resource Core Centers that contribute to advancing research in kidney, urology, and hematology diseases. These centers play a critical role in strengthening national biomedical research infrastructure by providing shared access to specialized resources that are otherwise difficult to obtain or maintain independently. The primary purpose of this grant is to establish centralized resource hubs that can disseminate valuable research assets such as datasets, biological reagents, experimental models, analytical tools, and specialized services. These centers are expected to facilitate collaboration across the scientific community by enabling investigators to leverage shared expertise and infrastructure. A key structural component of the program is the integration of these Resource Core Centers into a broader national network coordinated by a designated Center Coordinating Hub operating under a separate funding mechanism. This networked approach is intended to enhance efficiency, reduce duplication of effort, and accelerate scientific discovery. Funding under this opportunity is expected to support multiple awards, with an anticipated total of approximately twenty Resource Core Centers nationwide. While specific award amounts and total program funding levels are not disclosed in the forecast, the scale and scope suggest substantial institutional support for large, collaborative research initiatives. Importantly, there is no cost sharing or matching requirement associated with this opportunity, reducing financial barriers for eligible applicants and encouraging broad participation across sectors. Eligibility for this grant is extensive and inclusive, encompassing a wide range of organizational types. Eligible applicants include public and private institutions of higher education, nonprofit organizations with or without 501(c)(3) status, state and local governments, tribal governments and organizations, independent school districts, small businesses, and for profit entities. Additional eligible entities include federal agencies, U.S. territories, faith based organizations, and regional organizations. This wide eligibility framework reflects the program’s emphasis on interdisciplinary collaboration and broad national participation. The application process is expected to follow standard NIH submission procedures, likely requiring electronic submission through designated federal grant portals. While specific application components are not detailed in the forecast, applicants should anticipate preparing comprehensive proposals outlining the proposed resource core infrastructure, governance, user access policies, and integration with the broader network. Evaluation criteria will likely focus on scientific merit, innovation, feasibility, and the potential to significantly advance research capabilities in the targeted disease areas. The timeline for this opportunity is currently in the forecast stage. The estimated posting date is December 1, 2026, with an anticipated application due date of January 30, 2027. Awards are expected to be announced around November 1, 2027, with project start dates beginning December 1, 2027. As a forecasted opportunity, these dates are subject to change, but they provide a clear planning horizon for prospective applicants. Interested organizations are encouraged to monitor updates and prepare in advance for the formal release of the funding announcement.